Woo‐Sung Min
The Catholic University of Korea Seoul St. Mary's Hospital(KR)Catholic University of Korea(KR)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, T-cell and B-cell Immunology, Myeloproliferative Neoplasms: Diagnosis and Treatment
Most-Cited Works
- → The extent of minimal residual disease reduction after the first 4‐week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia(2009)49 cited
- → Cytogenetic profiles of 2806 patients with acute myeloid leukemia—a retrospective multicenter nationwide study(2016)40 cited
- → Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation(2016)34 cited
- → Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation(2017)34 cited
- → Current Trends of Infectious Complications following Hematopoietic Stem Cell Transplantation in a Single Center(2006)29 cited
- → JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia(2010)18 cited
- → Influence of karyotype on outcome of allogeneic bone marrow transplantation for adults with precursor B‐lineage acute lymphoblastic leukaemia in first or second remission(2002)18 cited
- → Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or older(2007)15 cited
- → Clinical Characteristics and Outcomes of Posttransplant Lymphoproliferative Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation in Korea(2006)12 cited
- → Usefulness of Real-time Semi-quantitative PCR, JAK2 MutaScreenTM Kit for JAK2 V617F Screening(2009)9 cited